Gene · 713
C1QB: complement C1q B chain
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. C1QB: complement C1q B chain. Genes, record 713. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/713
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P02746 | Complement C1q subcomponent subunit B | 253 | 11 | GeneID, HGNC |
Source UniProt
Patents97
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026028257 A | 2026-02-19 | 2 | P02746 | Espacenet |
| US 12534522 B2 | 2026-01-27 | 2 | P02746 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 41962 | P02746 | Espacenet |
| EP 4670793 A1 | 2025-12-31 | 7 | P02746 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4933 | P02746 | Espacenet |
| JP 2025533847 A | 2025-10-09 | 23 | P02746 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 1776 | P02746 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5655 | P02746 | Espacenet |
| WO 2025165658 A1 | 2025-08-07 | 34 | P02746 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5655 | P02746 | Espacenet |
1 to 10 of 97
See all 97 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,457
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | C1QB papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 5 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 5 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| T32AI007290 | Molecular and Cellular Immunobiology | 4 | 2025 |
| U19AI057266 | Vaccine and Infection Induced Immunity in the Young and Aged | 4 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 3 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 3 | 2025 |
1 to 10 of 1,457Source NIH's project files
See all 1,457 nih grantsPapers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics analyses demonstrate complement dysregulation is involved in focal segmental glomerulosclerosis. | Front Immunol | 2026 | 42780117 | PubTator, text mining | PubMed |
| Nocardia lung infection in severe asthma with immune dysfunction. | J Asthma | 2026 | 42742958 | PubTator, text mining | PubMed |
| An Investigation to Study Morphology, Nanomechanical Attributes, Transcriptomics, and Proteomics of Tumor Associated Macrophages Derived Extracellular Vesicles in the Tumor Microenvironment. | J Anal Oncol | 2026 | 42719843 | PubTator, text mining | PubMed |
| Proteomic profiling of cephalic vein reveals potential biomarkers for arteriovenous fistula neointimal hyperplasia in ESRD patients. | Ren Fail | 2026 | 42703036 | PubTator, text mining | PubMed |
| Complement Activation Linked to Type II Interferon Signaling in Still Disease. | Arthritis Rheumatol | 2026 | 42640011 | PubTator, text mining | PubMed |
| Comparative assessment of host transcriptomic- and bacteriological- markers for monitoring treatment response among active tuberculosis patients: a longitudinal study. | Int J Infect Dis | 2026 | 42419448 | PubTator, text mining | PubMed |
| Exploring shared biomarkers and their mechanisms in thyroid cancer and systemic lupus erythematosus via bioinformatics analysis. | Discov Oncol | 2026 | 42348043 | PubTator, text mining | PubMed |
| Integrated Transcriptomic Analysis Suggests a C1Q-Related Macrophage-Fibroblast Signaling Axis in Keloids. | Int J Mol Sci | 2026 | 42278663 | PubTator, text mining | PubMed |
| Genetic landscape of early-onset systemic lupus erythematous in India. | Rheumatology (Oxford) | 2026 | 42251732 | PubTator, text mining | PubMed |
| Exploration of common immune mechanisms and hub genes in latent and active tuberculosis infection. | Front Cell Infect Microbiol | 2026 | 42245998 | PubTator, text mining | PubMed |
1 to 10 of 1,828
See all 1,828 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/713
GET https://conductscience.org/api/genes/v1/713/patents?page=2